Safe Continuation of Pegvisomant During Pregnancy in a Patient With Fibrous Dysplasia/McCune-Albright Syndrome. [PDF]
Tan JY +4 more
europepmc +1 more source
Developing a Standardised Dataset for Natural History Studies in Fibrous Dysplasia/McCune-Albright Syndrome. [PDF]
Priego Zurita AL +19 more
europepmc +1 more source
Burosumab treatment of a child with McCune-Albright syndrome/polyostotic fibrous dysplasia: challenges and benefits. [PDF]
Sakka SD +6 more
europepmc +1 more source
Use of burosumab in McCune Albright syndrome: case report and review of literature in mosaic disorders with FGF23 overproduction. [PDF]
Barbato A +6 more
europepmc +1 more source
[Precocious puberty in the McCune-Albright Syndrome: a case report]. [PDF]
Rifai K +4 more
europepmc +1 more source
Burosumab treatment for fibroblast growth factor-23-associated hypophosphatemia in an adult patient with severe fibrous dysplasia in McCune-Albright syndrome: case report and review of the literature. [PDF]
Stelmachowska-Banaś M +4 more
europepmc +1 more source
McCune-Albright syndrome: a case of an adult with fibrous dysplasia, severe cardiopulmonary complications, acromegaly, and chronic myeloid leukemia. [PDF]
Ji A, McLean A, Sinha A.
europepmc +1 more source
Posterior Reversible Encephalopathy Syndrome in the Context of McCune-Albright Syndrome: A Case Report. [PDF]
Astara K +4 more
europepmc +1 more source
McCune–Albright Syndrome: Anesthetic Considerations in Neurointerventional Suite
Gulshan Kumar +3 more
doaj +1 more source
Early Manifestation of McCune-Albright Syndrome in a 32-Month-Old Female: A Rare Case Report. [PDF]
Makhlouf TZ +5 more
europepmc +1 more source

